Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Monitor Psychotropic Medication Use and Side Effects

Mount Vernon, Washington Survey Completed on 06-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents received appropriate medication-specific monitoring for psychotropic medications, specifically antidepressants. One resident, with a history of depression and anxiety, was admitted and subsequently hospitalized after experiencing a side effect from their antidepressant medication, resulting in Syndrome of Inappropriate Antidiuretic Hormone (SIADH) and low sodium levels. Despite the resident's history and diagnosis, there was no depression symptom monitoring in place upon admission, and after a new antidepressant was started, there was no implementation of target behavior monitoring, side effect monitoring, or updates to the care plan. The resident had also initially denied depression symptoms but later disclosed ongoing depression, which was confirmed by a standardized screening tool, yet no monitoring was initiated following this disclosure. Another newly admitted resident with a diagnosis of depression was prescribed two different antidepressant medications without any associated behavior monitors, medication side effect monitors, or non-pharmacological interventions. Staff interviews confirmed that these monitoring measures were not in place for this resident. The lack of monitoring and care plan updates for both residents was acknowledged by facility staff, who stated that these components had been missed.

An unhandled error has occurred. Reload 🗙